Resolution of secondary pulmonary alveolar proteinosis following treatment of rhinocerebral aspergillosis

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Kun-Pei LinShang-Chwen Chang

Abstract

Pulmonary alveolar proteinosis can be secondary to inhaled dust exposure, malignancy, and chronic pulmonary infections. However, pulmonary alveolar proteinosis secondary to extrapulmonary aspergillosis has never been reported. We report herein a case of pulmonary alveolar proteinosis secondary to invasive rhinocerebral aspergillosis. Neither immune modulators nor whole lung lavage was applied during the treatment course. The severe respiratory distress subsided, hypoxia resolved, and radiological infiltrates improved following the successful treatment of invasive rhinocerebral aspergillosis alone.

References

Apr 1, 1991·The Journal of Antimicrobial Chemotherapy·N ColletteA Coune
May 1, 1984·The Annals of Otology, Rhinology, and Laryngology·H StammbergerF Beaufort
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·C CordonnierJ F Bernaudin
Apr 1, 1994·The Annals of Otology, Rhinology, and Laryngology·D SaahA Nagler
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Nov 1, 1996·Respiratory Medicine·L J CoudercI Caubarrere
Oct 6, 1997·Bone Marrow Transplantation·M Rodríguez-LuacesF Hernández-Navarro
Jun 5, 1958·The New England Journal of Medicine·S H ROSENA A LIEBOW
Aug 28, 2004·Clinics in Chest Medicine·Jeffrey J PresneillJohn F Seymour
Aug 19, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Noel R WardwellLorraine B Ware
Jan 25, 2007·Occupational Medicine·Riitta SauniJ Uitti

❮ Previous
Next ❯

Citations

Dec 17, 2015·Internal Medicine·Toru AraiMasanori Kitaichi
May 13, 2021·Respirology Case Reports·Hsiang-Shi ShenShi-Chuan Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.